Exosomal proteomic profiling revealed children type 1 diabete pathogenesis and potential therapeutic targets
Ontology highlight
ABSTRACT: Abstract Introduction: Type 1 diabetes (T1D) is a serious autoimmune disease with high morbidity and mortality. Early diagnosis and treatment remain unsatisfactory. Circulating exosomes containing T1D biomarkers have gained interest, but progress is limited. Objectives: This study investigates molecular dynamics of plasma exosomes in pediatric T1D patients and reveals potential mechanisms associated with T1D development. Methods: Liquid chromatography-tandem mass spectrometry with TMT6 labeling quantified exosomal protein expression profiles in 12 healthy and 24 pediatric T1D patients, stratified by age (≤6 years and >6 years) and glycated hemoglobin (HbA1c) levels (>7% or ≤7%). Integrative bioinformatics analyses were conducted, and Western Blot (WB) validated findings. Results: We identified 1035 proteins, revealing 548 and 589 differentially expressed proteins (fold change >1.3) in T1D patients aged ≤6 and >6 years, respectively. When HbA1c was below 7% (received insulin therapy for at least three months), most of the altered protein levels in both age groups resembled healthy controls. Bioinformatics analysis indicated exosome components related to immune functions, hemostasis, cellular stress response, and extracellular matrix organization. WB confirmed alterations in RAB40A, COL6A5, SEMA6D, and TTR proteins. Conclusion: Our study characterizes plasma exosome protein dynamics in pediatric T1D patients across age stages, providing valuable insights into molecular mechanisms and identifying potential therapeutic targets for T1D management.
ORGANISM(S): Homo Sapiens
SUBMITTER: Qin Zhang
PROVIDER: PXD043146 | iProX | Tue Jun 20 00:00:00 BST 2023
REPOSITORIES: iProX
ACCESS DATA